{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:31:13Z","timestamp":1770978673615,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,14]]},"DOI":"10.7759\/cureus.64502","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T07:29:27Z","timestamp":1720942167000},"source":"Crossref","is-referenced-by-count":1,"title":["Navigating the Diagnostic Maze: A Case Report of Immunoglobulin G4-Related Disease"],"prefix":"10.7759","author":[{"given":"Muhammad Ayub","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeem","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajeeh","family":"Ur Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzammil Ahmad","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone JH","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012, 366:539-51. 10.1056\/NEJMra1104650","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano H","year":"2001","unstructured":"Hamano H, Kawa S, Horiuchi A, et al.. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001, 344:732-8. 10.1056\/NEJM200103083441005","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh447","article-title":"Clinical and pathological differences between Mikulicz's disease and Sj\u00f6gren's syndrome","volume":"44","author":"Yamamoto M","year":"2005","unstructured":"Yamamoto M, Harada S, Ohara M, et al.. Clinical and pathological differences between Mikulicz's disease and Sj\u00f6gren's syndrome. Rheumatology (Oxford). 2005, 44:227-34. 10.1093\/rheumatology\/keh447","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181c811ad","article-title":"Chronic sclerosing sialadenitis (K\u00fcttner tumor) is an IgG4-associated disease","volume":"34","author":"Geyer JT","year":"2010","unstructured":"Geyer JT, Ferry JA, Harris NL, et al.. Chronic sclerosing sialadenitis (K\u00fcttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010, 34:202-10. 10.1097\/PAS.0b013e3181c811ad","journal-title":"Am J Surg Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa T","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, et al.. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003, 38:982-4. 10.1007\/s00535-003-1175-y","journal-title":"J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen Y","year":"2010","unstructured":"Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010, 34:1812-9. 10.1097\/PAS.0b013e3181f7266b","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace ZS","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, Stone JH. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015, 67:2466-75. 10.1002\/art.39205","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.39686","article-title":"IgG4-related disease: retrospective analysis of one hundred sixty-six patients","volume":"68","author":"Sekiguchi H","year":"2016","unstructured":"Sekiguchi H, Horie R, Kanai M, Suzuki R, Yi ES, Ryu JH. IgG4-related disease: retrospective analysis of one hundred sixty-six patients. Arthritis Rheumatol. 2016, 68:2290-9. 10.1002\/art.39686","journal-title":"Arthritis Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0079-3","article-title":"IgG4-related disease: a systematic review of this unrecognized disease in pediatrics","volume":"14","author":"Karim F","year":"2016","unstructured":"Karim F, Loeffen J, Bramer W, Westenberg L, Verdijk R, van Hagen M, van Laar J. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online J. 2016, 14:18. 10.1186\/s12969-016-0079-3","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283412f4a","article-title":"Pathogenesis of IgG4-related disease","volume":"23","author":"Zen Y","year":"2011","unstructured":"Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol. 2011, 23:114-8. 10.1097\/BOR.0b013e3283412f4a","journal-title":"Curr Opin Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo H","year":"2016","unstructured":"Mattoo H, Mahajan VS, Maehara T, et al.. Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016, 138:825-38. 10.1016\/j.jaci.2015.12.1330","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004002","article-title":"Therapeutic approach to IgG4-related disease: a systematic review","volume":"95","author":"Brito-Zer\u00f3n P","year":"2016","unstructured":"Brito-Zer\u00f3n P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Therapeutic approach to IgG4-related disease: a systematic review. Medicine (Baltimore). 2016, 95:e4002. 10.1097\/MD.0000000000004002","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara H","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, et al.. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012, 22:21-30. 10.1007\/s10165-011-0571-z","journal-title":"Mod Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi A","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, et al.. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015, 67:1688-99. 10.1002\/art.39132","journal-title":"Arthritis Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers MN","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, et al.. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015, 74:1171-7. 10.1136\/annrheumdis-2014-206605","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi A","year":"2012","unstructured":"Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore). 2012, 91:57-66. 10.1097\/MD.0b013e3182431ef6","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/267261-navigating-the-diagnostic-maze-a-case-report-of-immunoglobulin-g4-related-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T07:29:30Z","timestamp":1720942170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/267261-navigating-the-diagnostic-maze-a-case-report-of-immunoglobulin-g4-related-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,14]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.64502","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,14]]}}}